Local Charity Joins International Coalition to Fund UNC-Chapel Hill Genetics Research

Jasper Against Batten at Cures Within Reach, a 501(c)3 not-for-profit located in IL, is collaborating with an int'l coalition to fund “Global Gene Transfer for Batten Disease” research at the UNC Gene Therapy Center, announced Dr. Bruce Bloom.
 
 
Jasper Against Batten logo
Jasper Against Batten logo
March 5, 2013 - PRLog -- Jasper Against Batten @ Cures Within Reach and four other American organizations are joining forces with Bee for Battens, the National Batten Disease Charity of Ireland, to provide funding to support its research initiatives. The American organizations are Jasper Against Batten, Taylor’s Tale, Drew’s Hope, Hayden’s Batten Disease Foundation, Inc. and A Cure for Nick.

The collaborating organizations were founded by family and friends of children afflicted with Batten disease, which is one of approximately 7,000 rare diseases that afflict 30 million people in the United States, or one in 10 Americans, and an estimated 350 million people worldwide. The cost in terms of human suffering and huge financial burdens make finding rare disease treatments a top public health priority.

Principal Investigator Steven Gray, Ph.D. is a member of the research team at the Gene Therapy Center at UNC. He is leading the Global Gene Transfer for Batten Disease project, which is modeled after a project at UNC that is focused on the ultra-rare childhood disease Giant Axonal Neuropathy (GAN) and is a parallel study in infantile (INCL, CLN1 mutation) and late infantile (LINCL, CLN2 mutation) Batten disease.

The project aims to test a global gene delivery platform in mouse models for INCL and LINCL, to see if it imparts a therapeutic benefit over previous gene therapy approaches.  If these studies are successful, existing large animal biodistribution studies would pave a clear path forward for human translation following appropriate toxicology studies.

For human applications, the AAV-based intrathecal gene delivery platform would provide these benefits:

·         A minimally-invasive injection route

·         A moderate dose that could be readily manufactured at clinical grade by the Gene Therapy Center

·         Efficient expression of the therapeutic gene throughout the entire brain and spinal cord volume that can be scaled to humans

For more information, visit:

Jasper Against Batten @ Cures Within Reach

(www.JasperAgainstBatten.org or www.4cures.org)

BeeforBattens, the National Batten Disease Charity of Ireland

(www.BeeForBattens.org)

UNC-Chapel Hill Gene Therapy Center

(http://genetherapy.unc.edu/)

National Organization for Rare Disorders

(www.rarediseases.org)

Batten Disease Support and Research Association (BDSRA) (www.bdsra.org)

Media contact at Cures Within Reach: Amy Conn

312-696-1369

Amy.conn@cureswithinreach.org
End
Source: » Follow
Email:***@4cures.org Email Verified
Zip:60602
Tags:Philanthropy, Rare Disease, Orphan Disease, Funding, Medical
Industry:Health, Research
Location:Chicago - Illinois - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cures Within Reach News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share